Literature DB >> 19668190

Immortalization eliminates a roadblock during cellular reprogramming into iPS cells.

Jochen Utikal1, Jose M Polo, Matthias Stadtfeld, Nimet Maherali, Warakorn Kulalert, Ryan M Walsh, Adam Khalil, James G Rheinwald, Konrad Hochedlinger.   

Abstract

The overexpression of defined transcription factors in somatic cells results in their reprogramming into induced pluripotent stem (iPS) cells. The extremely low efficiency and slow kinetics of in vitro reprogramming suggest that further rare events are required to generate iPS cells. The nature and identity of these events, however, remain elusive. We noticed that the reprogramming potential of primary murine fibroblasts into iPS cells decreases after serial passaging and the concomitant onset of senescence. Consistent with the notion that loss of replicative potential provides a barrier for reprogramming, here we show that cells with low endogenous p19(Arf) (encoded by the Ink4a/Arf locus, also known as Cdkn2a locus) protein levels and immortal fibroblasts deficient in components of the Arf-Trp53 pathway yield iPS cell colonies with up to threefold faster kinetics and at a significantly higher efficiency than wild-type cells, endowing almost every somatic cell with the potential to form iPS cells. Notably, the acute genetic ablation of Trp53 (also known as p53) in cellular subpopulations that normally fail to reprogram rescues their ability to produce iPS cells. Our results show that the acquisition of immortality is a crucial and rate-limiting step towards the establishment of a pluripotent state in somatic cells and underscore the similarities between induced pluripotency and tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19668190      PMCID: PMC3987892          DOI: 10.1038/nature08285

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  29 in total

Review 1.  Epigenetic reprogramming and induced pluripotency.

Authors:  Konrad Hochedlinger; Kathrin Plath
Journal:  Development       Date:  2009-02       Impact factor: 6.868

2.  Two supporting factors greatly improve the efficiency of human iPSC generation.

Authors:  Yang Zhao; Xiaolei Yin; Han Qin; Fangfang Zhu; Haisong Liu; Weifeng Yang; Qiang Zhang; Chengang Xiang; Pingping Hou; Zhihua Song; Yanxia Liu; Jun Yong; Pengbo Zhang; Jun Cai; Meng Liu; Honggang Li; Yanqin Li; Xiuxia Qu; Kai Cui; Weiqi Zhang; Tingting Xiang; Yetao Wu; Yiding Zhao; Chun Liu; Chen Yu; Kehu Yuan; Jinning Lou; Mingxiao Ding; Hongkui Deng
Journal:  Cell Stem Cell       Date:  2008-11-06       Impact factor: 24.633

3.  Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.

Authors:  Matthias Stadtfeld; Nimet Maherali; David T Breault; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-02-14       Impact factor: 24.633

4.  Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.

Authors:  Nimet Maherali; Rupa Sridharan; Wei Xie; Jochen Utikal; Sarah Eminli; Katrin Arnold; Matthias Stadtfeld; Robin Yachechko; Jason Tchieu; Rudolf Jaenisch; Kathrin Plath; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2007-06-07       Impact factor: 24.633

5.  Improved efficiency and pace of generating induced pluripotent stem cells from human adult and fetal fibroblasts.

Authors:  Prashant Mali; Zhaohui Ye; Holly H Hommond; Xiaobing Yu; Jeff Lin; Guibin Chen; Jizhong Zou; Linzhao Cheng
Journal:  Stem Cells       Date:  2008-05-29       Impact factor: 6.277

6.  Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells.

Authors:  Sarah Eminli; Adlen Foudi; Matthias Stadtfeld; Nimet Maherali; Tim Ahfeldt; Gustavo Mostoslavsky; Hanno Hock; Konrad Hochedlinger
Journal:  Nat Genet       Date:  2009-08-09       Impact factor: 38.330

7.  A drug-inducible system for direct reprogramming of human somatic cells to pluripotency.

Authors:  Dirk Hockemeyer; Frank Soldner; Elizabeth G Cook; Qing Gao; Maisam Mitalipova; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

8.  A high-efficiency system for the generation and study of human induced pluripotent stem cells.

Authors:  Nimet Maherali; Tim Ahfeldt; Alessandra Rigamonti; Jochen Utikal; Chad Cowan; Konrad Hochedlinger
Journal:  Cell Stem Cell       Date:  2008-09-11       Impact factor: 24.633

9.  Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.

Authors:  Jacob Hanna; Styliani Markoulaki; Patrick Schorderet; Bryce W Carey; Caroline Beard; Marius Wernig; Menno P Creyghton; Eveline J Steine; John P Cassady; Ruth Foreman; Christopher J Lengner; Jessica A Dausman; Rudolf Jaenisch
Journal:  Cell       Date:  2008-04-18       Impact factor: 41.582

10.  A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types.

Authors:  Marius Wernig; Christopher J Lengner; Jacob Hanna; Michael A Lodato; Eveline Steine; Ruth Foreman; Judith Staerk; Styliani Markoulaki; Rudolf Jaenisch
Journal:  Nat Biotechnol       Date:  2008-07-01       Impact factor: 54.908

View more
  408 in total

1.  Evidence for premature aging due to oxidative stress in iPSCs from Cockayne syndrome.

Authors:  Luciana Nogueira de Sousa Andrade; Jason L Nathanson; Gene W Yeo; Carlos Frederico Martins Menck; Alysson Renato Muotri
Journal:  Hum Mol Genet       Date:  2012-06-01       Impact factor: 6.150

Review 2.  From microRNAs to targets: pathway discovery in cell fate transitions.

Authors:  Deepa Subramanyam; Robert Blelloch
Journal:  Curr Opin Genet Dev       Date:  2011-06-01       Impact factor: 5.578

Review 3.  Nuclear reprogramming to a pluripotent state by three approaches.

Authors:  Shinya Yamanaka; Helen M Blau
Journal:  Nature       Date:  2010-06-10       Impact factor: 49.962

Review 4.  EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer.

Authors:  A Singh; J Settleman
Journal:  Oncogene       Date:  2010-06-07       Impact factor: 9.867

5.  Rational design of cyclic peptide modulators of the transcriptional coactivator CBP: a new class of p53 inhibitors.

Authors:  Guillermo Gerona-Navarro; Shiraz Mujtaba; Antonio Frasca; Jigneshkumar Patel; Lei Zeng; Alexander N Plotnikov; Roman Osman; Ming-Ming Zhou
Journal:  J Am Chem Soc       Date:  2011-01-27       Impact factor: 15.419

Review 6.  Learning the molecular mechanisms of the reprogramming factors: let's start from microRNAs.

Authors:  Chao-Shun Yang; Tariq M Rana
Journal:  Mol Biosyst       Date:  2012-10-05

Review 7.  Mechanisms underlying the formation of induced pluripotent stem cells.

Authors:  Federico González; Danwei Huangfu
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2015-09-18       Impact factor: 5.814

8.  Lineage Plasticity in Cancer Progression and Treatment.

Authors:  Clémentine Le Magnen; Michael M Shen; Cory Abate-Shen
Journal:  Annu Rev Cancer Biol       Date:  2017-12-01

Review 9.  Translating induced pluripotent stem cells from bench to bedside: application to retinal diseases.

Authors:  Alona O Cramer; Robert E MacLaren
Journal:  Curr Gene Ther       Date:  2013-04       Impact factor: 4.391

10.  Induction of retinal progenitors and neurons from mammalian Müller glia under defined conditions.

Authors:  Jack Jiagang Zhao; Hong Ouyang; Jing Luo; Sherrina Patel; Yuanchao Xue; John Quach; Nicole Sfeir; Meixia Zhang; Xiangdong Fu; Sheng Ding; Shaochen Chen; Kang Zhang
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.